Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 4Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Interventional × polyphenon E × Clear all
NCT00707252 2015-04-21

Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer

Louisiana State University Health Sciences Center Shreveport

Phase 1 Terminated
11 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00459407 2014-10-08

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

National Cancer Institute (NCI)

Phase 1 Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT00516243 2014-09-12

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Breast

Breast Neoplasms

NCT00233935 2014-09-11

Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus

National Cancer Institute (NCI)

Phase 1 Completed
55 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡